Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oncolytic Virotherapy | 33 | 2024 | 515 | 6.920 |
Why?
|
Glioblastoma | 61 | 2024 | 3482 | 4.860 |
Why?
|
Oncolytic Viruses | 22 | 2024 | 343 | 4.330 |
Why?
|
Brain Neoplasms | 83 | 2024 | 8984 | 4.240 |
Why?
|
Simplexvirus | 29 | 2023 | 803 | 3.630 |
Why?
|
Meningioma | 22 | 2024 | 1220 | 3.210 |
Why?
|
Meningeal Neoplasms | 22 | 2024 | 1248 | 2.810 |
Why?
|
Glioma | 38 | 2024 | 3420 | 2.470 |
Why?
|
Neoplastic Stem Cells | 24 | 2024 | 1347 | 2.250 |
Why?
|
Isocitrate Dehydrogenase | 15 | 2024 | 927 | 1.680 |
Why?
|
Herpes Simplex | 6 | 2024 | 477 | 1.060 |
Why?
|
Xenograft Model Antitumor Assays | 30 | 2024 | 3584 | 1.020 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 4 | 2020 | 84 | 1.000 |
Why?
|
Tumor Microenvironment | 14 | 2024 | 3826 | 0.950 |
Why?
|
NAD | 6 | 2021 | 610 | 0.930 |
Why?
|
Proto-Oncogene Proteins c-myc | 4 | 2019 | 995 | 0.930 |
Why?
|
Astrocytoma | 3 | 2024 | 775 | 0.910 |
Why?
|
Genetic Vectors | 23 | 2024 | 3378 | 0.880 |
Why?
|
Cyanides | 2 | 2020 | 83 | 0.860 |
Why?
|
Hyaluronoglucosaminidase | 2 | 2020 | 135 | 0.840 |
Why?
|
Herpesvirus 1, Human | 6 | 2023 | 753 | 0.830 |
Why?
|
Guanidines | 2 | 2020 | 193 | 0.830 |
Why?
|
Adenoviridae | 15 | 2024 | 1084 | 0.820 |
Why?
|
Cell Line, Tumor | 45 | 2024 | 16905 | 0.790 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 367 | 0.780 |
Why?
|
Mice | 87 | 2024 | 81216 | 0.770 |
Why?
|
Retinoblastoma Protein | 1 | 2023 | 671 | 0.690 |
Why?
|
Chromosomes, Artificial, Bacterial | 2 | 2019 | 122 | 0.670 |
Why?
|
Drug Resistance, Neoplasm | 13 | 2022 | 5230 | 0.660 |
Why?
|
Animals | 107 | 2024 | 167940 | 0.660 |
Why?
|
Stereotaxic Techniques | 1 | 2021 | 549 | 0.650 |
Why?
|
DNA Mismatch Repair | 2 | 2020 | 429 | 0.640 |
Why?
|
Cerebrospinal Fluid | 1 | 2021 | 544 | 0.630 |
Why?
|
Pericytes | 1 | 2020 | 292 | 0.600 |
Why?
|
Central Nervous System Neoplasms | 2 | 2023 | 917 | 0.590 |
Why?
|
Mice, SCID | 13 | 2020 | 2627 | 0.570 |
Why?
|
Endopeptidases | 1 | 2020 | 772 | 0.560 |
Why?
|
Specimen Handling | 1 | 2021 | 708 | 0.560 |
Why?
|
Tumor Cells, Cultured | 26 | 2020 | 6131 | 0.550 |
Why?
|
Molecular Targeted Therapy | 8 | 2024 | 2805 | 0.520 |
Why?
|
Mutation | 27 | 2024 | 29950 | 0.520 |
Why?
|
Neurofibromin 2 | 4 | 2024 | 270 | 0.510 |
Why?
|
Cytokines | 8 | 2022 | 7345 | 0.480 |
Why?
|
Piperazines | 6 | 2024 | 2520 | 0.460 |
Why?
|
Immunotherapy | 13 | 2024 | 4637 | 0.460 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 5 | 2024 | 896 | 0.440 |
Why?
|
Cell Cycle Proteins | 5 | 2019 | 3448 | 0.430 |
Why?
|
Disease Models, Animal | 23 | 2024 | 18134 | 0.420 |
Why?
|
Indazoles | 1 | 2014 | 302 | 0.420 |
Why?
|
Virus Replication | 14 | 2018 | 2431 | 0.400 |
Why?
|
Cell Proliferation | 18 | 2024 | 10434 | 0.400 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 620 | 0.380 |
Why?
|
Gene Expression Regulation, Neoplastic | 13 | 2021 | 8498 | 0.380 |
Why?
|
Humans | 149 | 2024 | 760261 | 0.380 |
Why?
|
Antineoplastic Agents, Alkylating | 5 | 2020 | 619 | 0.380 |
Why?
|
Apoptosis | 20 | 2019 | 9497 | 0.380 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2022 | 11708 | 0.360 |
Why?
|
Oligodendroglioma | 2 | 2024 | 279 | 0.350 |
Why?
|
Viruses | 3 | 2003 | 376 | 0.350 |
Why?
|
Transforming Growth Factor beta | 1 | 2017 | 1956 | 0.340 |
Why?
|
Proto-Oncogene Proteins c-akt | 9 | 2024 | 2449 | 0.340 |
Why?
|
Interleukin-12 | 5 | 2018 | 584 | 0.330 |
Why?
|
Immune Evasion | 3 | 2024 | 362 | 0.330 |
Why?
|
Membrane Proteins | 3 | 2020 | 7854 | 0.330 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 6 | 2018 | 192 | 0.320 |
Why?
|
Melanoma, Experimental | 6 | 2017 | 562 | 0.320 |
Why?
|
Ki-67 Antigen | 9 | 2022 | 631 | 0.310 |
Why?
|
Dacarbazine | 3 | 2017 | 560 | 0.310 |
Why?
|
TOR Serine-Threonine Kinases | 4 | 2019 | 2058 | 0.310 |
Why?
|
Imidazoles | 1 | 2014 | 1178 | 0.310 |
Why?
|
Mesenchymal Stem Cells | 5 | 2021 | 1634 | 0.310 |
Why?
|
Proto-Oncogene Proteins | 2 | 2018 | 4494 | 0.310 |
Why?
|
Mice, Nude | 13 | 2019 | 3605 | 0.300 |
Why?
|
Pyrimidines | 6 | 2022 | 3011 | 0.300 |
Why?
|
Neoplasm Recurrence, Local | 16 | 2024 | 9274 | 0.300 |
Why?
|
Neoplasms | 8 | 2024 | 22066 | 0.300 |
Why?
|
Complement Inactivator Proteins | 3 | 2004 | 77 | 0.300 |
Why?
|
Angiogenesis Inhibitors | 2 | 2014 | 2047 | 0.290 |
Why?
|
RNA, Messenger | 9 | 2022 | 12762 | 0.290 |
Why?
|
Gene Deletion | 4 | 2024 | 2668 | 0.270 |
Why?
|
Protein Kinase Inhibitors | 9 | 2024 | 5640 | 0.270 |
Why?
|
Phthalazines | 2 | 2020 | 377 | 0.260 |
Why?
|
Antineoplastic Agents | 10 | 2024 | 13629 | 0.260 |
Why?
|
Pteridines | 2 | 2018 | 47 | 0.260 |
Why?
|
Enzyme Inhibitors | 6 | 2024 | 3726 | 0.250 |
Why?
|
Antibodies, Bispecific | 2 | 2019 | 191 | 0.250 |
Why?
|
Cancer Vaccines | 3 | 2023 | 1044 | 0.250 |
Why?
|
Complement System Proteins | 4 | 2003 | 782 | 0.240 |
Why?
|
Vero Cells | 5 | 2019 | 484 | 0.240 |
Why?
|
Transfection | 8 | 2019 | 5782 | 0.240 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2024 | 70 | 0.240 |
Why?
|
Signal Transduction | 15 | 2023 | 23363 | 0.240 |
Why?
|
Purine-Nucleoside Phosphorylase | 1 | 2024 | 28 | 0.230 |
Why?
|
Glucose | 1 | 2016 | 4361 | 0.230 |
Why?
|
Foramen Magnum | 1 | 2024 | 41 | 0.230 |
Why?
|
Neoplasm Proteins | 6 | 2018 | 3613 | 0.230 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5248 | 0.220 |
Why?
|
Viral Proteins | 3 | 2018 | 1802 | 0.220 |
Why?
|
Injections, Intralesional | 3 | 2020 | 278 | 0.220 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2024 | 698 | 0.220 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 5 | 2023 | 886 | 0.220 |
Why?
|
DNA Damage | 3 | 2020 | 2442 | 0.210 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2018 | 666 | 0.210 |
Why?
|
Methionine | 2 | 2024 | 569 | 0.210 |
Why?
|
Acetonitriles | 1 | 2022 | 54 | 0.210 |
Why?
|
Interleukin-2 | 4 | 2024 | 1890 | 0.200 |
Why?
|
Homozygote | 2 | 2024 | 1786 | 0.200 |
Why?
|
SOXB1 Transcription Factors | 2 | 2015 | 286 | 0.200 |
Why?
|
Genetic Engineering | 3 | 2018 | 933 | 0.200 |
Why?
|
Cyclophosphamide | 4 | 2004 | 2220 | 0.200 |
Why?
|
Cisterna Magna | 1 | 2021 | 39 | 0.200 |
Why?
|
Up-Regulation | 3 | 2020 | 4127 | 0.200 |
Why?
|
Retroviridae | 5 | 1997 | 850 | 0.200 |
Why?
|
Female | 66 | 2024 | 391011 | 0.200 |
Why?
|
Embryonic Stem Cells | 1 | 2009 | 1262 | 0.190 |
Why?
|
Melanoma | 4 | 2024 | 5695 | 0.190 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2024 | 346 | 0.190 |
Why?
|
Acrylamides | 2 | 2020 | 260 | 0.190 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2021 | 84 | 0.190 |
Why?
|
Immunohistochemistry | 12 | 2019 | 11064 | 0.180 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2024 | 556 | 0.180 |
Why?
|
Aminopyridines | 1 | 2024 | 564 | 0.180 |
Why?
|
Antigens, CD | 4 | 2021 | 4002 | 0.180 |
Why?
|
Hexokinase | 1 | 2020 | 125 | 0.180 |
Why?
|
Hexanones | 1 | 2019 | 5 | 0.180 |
Why?
|
Genetic Heterogeneity | 2 | 2021 | 724 | 0.180 |
Why?
|
Glycoside Hydrolases | 1 | 2020 | 132 | 0.170 |
Why?
|
T-Lymphocytes | 5 | 2024 | 10183 | 0.170 |
Why?
|
Spinal Cord Neoplasms | 1 | 2022 | 264 | 0.170 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2020 | 184 | 0.170 |
Why?
|
IMP Dehydrogenase | 1 | 2019 | 33 | 0.170 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2024 | 2052 | 0.170 |
Why?
|
Transcription Factor RelA | 1 | 2020 | 251 | 0.170 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2020 | 454 | 0.170 |
Why?
|
Hyaluronic Acid | 2 | 2020 | 482 | 0.170 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2022 | 423 | 0.170 |
Why?
|
Sequence Deletion | 1 | 2023 | 1493 | 0.160 |
Why?
|
Immunity, Innate | 3 | 2024 | 3046 | 0.160 |
Why?
|
Aldehyde Oxidoreductases | 1 | 2019 | 87 | 0.160 |
Why?
|
Benzimidazoles | 1 | 2024 | 858 | 0.160 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2019 | 2874 | 0.160 |
Why?
|
Neoplasm Transplantation | 7 | 2017 | 2014 | 0.160 |
Why?
|
Pyridines | 3 | 2024 | 2877 | 0.160 |
Why?
|
Tachycardia | 1 | 2001 | 603 | 0.160 |
Why?
|
Cell Differentiation | 6 | 2024 | 11480 | 0.160 |
Why?
|
Lung Neoplasms | 3 | 2022 | 13249 | 0.160 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2019 | 147 | 0.160 |
Why?
|
Sirtuins | 1 | 2021 | 320 | 0.150 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 59 | 0.150 |
Why?
|
Permeability | 1 | 2020 | 719 | 0.150 |
Why?
|
Neural Stem Cells | 4 | 2012 | 884 | 0.150 |
Why?
|
Gene Silencing | 3 | 2021 | 1511 | 0.150 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2022 | 772 | 0.140 |
Why?
|
Dystrophin | 1 | 2018 | 284 | 0.140 |
Why?
|
Quinazolinones | 1 | 2019 | 223 | 0.140 |
Why?
|
DNA-Binding Proteins | 4 | 2020 | 9590 | 0.140 |
Why?
|
Interleukin-4 | 3 | 2006 | 1133 | 0.140 |
Why?
|
Hydroxyurea | 1 | 2018 | 283 | 0.140 |
Why?
|
Delayed-Action Preparations | 1 | 2020 | 961 | 0.140 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2017 | 131 | 0.140 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2022 | 2823 | 0.140 |
Why?
|
Oxazines | 1 | 2019 | 341 | 0.140 |
Why?
|
Cell Movement | 6 | 2020 | 5206 | 0.140 |
Why?
|
Autophagy | 3 | 2020 | 1336 | 0.140 |
Why?
|
Gene Transfer Techniques | 5 | 2002 | 1204 | 0.130 |
Why?
|
Rad51 Recombinase | 1 | 2017 | 188 | 0.130 |
Why?
|
Glycolysis | 2 | 2020 | 828 | 0.130 |
Why?
|
Amino Acid Transport System y+ | 1 | 2016 | 37 | 0.130 |
Why?
|
Glutarates | 3 | 2024 | 244 | 0.130 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2016 | 3483 | 0.130 |
Why?
|
RNA, Small Interfering | 5 | 2019 | 3443 | 0.130 |
Why?
|
Drug Carriers | 1 | 2020 | 706 | 0.130 |
Why?
|
Radiation Tolerance | 2 | 2016 | 480 | 0.130 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2019 | 656 | 0.130 |
Why?
|
Transduction, Genetic | 5 | 2009 | 897 | 0.130 |
Why?
|
Radiobiology | 1 | 2016 | 89 | 0.130 |
Why?
|
Cell Hypoxia | 2 | 2015 | 657 | 0.130 |
Why?
|
Cell Cycle | 7 | 2019 | 2937 | 0.130 |
Why?
|
Ribonuclease, Pancreatic | 1 | 2016 | 149 | 0.130 |
Why?
|
Neoplasm Invasiveness | 4 | 2012 | 3618 | 0.120 |
Why?
|
Transgenes | 1 | 2019 | 1006 | 0.120 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2019 | 2866 | 0.120 |
Why?
|
Mice, Inbred C57BL | 13 | 2024 | 22025 | 0.120 |
Why?
|
Nuclear Proteins | 6 | 2016 | 5793 | 0.120 |
Why?
|
Stromal Cells | 1 | 2020 | 1327 | 0.120 |
Why?
|
Extracellular Matrix | 2 | 2020 | 1726 | 0.120 |
Why?
|
Blotting, Western | 4 | 2017 | 5039 | 0.120 |
Why?
|
Macrophages | 3 | 2020 | 5745 | 0.120 |
Why?
|
Nucleoside Deaminases | 3 | 2002 | 58 | 0.120 |
Why?
|
BRCA2 Protein | 1 | 2020 | 797 | 0.120 |
Why?
|
Antigens, Neoplasm | 2 | 2021 | 1999 | 0.120 |
Why?
|
HEK293 Cells | 4 | 2017 | 4264 | 0.120 |
Why?
|
DNA Repair | 3 | 2020 | 2039 | 0.120 |
Why?
|
Neurodegenerative Diseases | 1 | 2024 | 1083 | 0.120 |
Why?
|
Antibodies, Neoplasm | 1 | 2016 | 280 | 0.120 |
Why?
|
Neoplasms, Experimental | 2 | 2019 | 1229 | 0.120 |
Why?
|
Introns | 1 | 2017 | 978 | 0.120 |
Why?
|
Telomerase | 4 | 2024 | 747 | 0.120 |
Why?
|
Piperidines | 2 | 2020 | 1650 | 0.120 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 1729 | 0.120 |
Why?
|
Survival Analysis | 7 | 2020 | 10185 | 0.120 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 2 | 2024 | 44 | 0.120 |
Why?
|
Neovascularization, Pathologic | 4 | 2018 | 2641 | 0.120 |
Why?
|
Glycoproteins | 2 | 2013 | 2208 | 0.120 |
Why?
|
Digoxin | 1 | 2015 | 247 | 0.120 |
Why?
|
Antibodies, Neutralizing | 1 | 2024 | 1933 | 0.120 |
Why?
|
DNA Replication | 2 | 2018 | 1412 | 0.110 |
Why?
|
Random Allocation | 2 | 2017 | 2394 | 0.110 |
Why?
|
Angiostatins | 1 | 2013 | 64 | 0.110 |
Why?
|
Vaccines, Synthetic | 1 | 1996 | 617 | 0.110 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2014 | 352 | 0.110 |
Why?
|
Blood-Brain Barrier | 1 | 2020 | 1017 | 0.110 |
Why?
|
Vesicular Transport Proteins | 1 | 2016 | 374 | 0.110 |
Why?
|
Polymers | 1 | 2020 | 1620 | 0.110 |
Why?
|
Mitosis | 1 | 2018 | 1193 | 0.110 |
Why?
|
BRCA1 Protein | 1 | 2020 | 1146 | 0.110 |
Why?
|
Biological Therapy | 1 | 2014 | 139 | 0.110 |
Why?
|
Transcription Factors | 6 | 2020 | 12100 | 0.110 |
Why?
|
DNA, Viral | 2 | 2017 | 2195 | 0.110 |
Why?
|
Rats, Nude | 5 | 2004 | 105 | 0.110 |
Why?
|
Genotype | 3 | 2018 | 12959 | 0.110 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1346 | 0.100 |
Why?
|
World Health Organization | 3 | 2023 | 1319 | 0.100 |
Why?
|
Prognosis | 11 | 2024 | 29636 | 0.100 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2016 | 633 | 0.100 |
Why?
|
Sulfones | 1 | 2015 | 447 | 0.100 |
Why?
|
Oligonucleotides | 1 | 2015 | 588 | 0.100 |
Why?
|
Single-Cell Analysis | 5 | 2024 | 2368 | 0.100 |
Why?
|
Gene Amplification | 1 | 2016 | 1085 | 0.100 |
Why?
|
Adaptive Immunity | 1 | 2016 | 724 | 0.100 |
Why?
|
Lymphoma | 1 | 2020 | 1899 | 0.090 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2011 | 74 | 0.090 |
Why?
|
Neoplasm Metastasis | 3 | 2018 | 4891 | 0.090 |
Why?
|
Down-Regulation | 1 | 2018 | 2918 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2024 | 4554 | 0.090 |
Why?
|
Dilazep | 1 | 2010 | 4 | 0.090 |
Why?
|
Equilibrative Nucleoside Transporter 1 | 1 | 2010 | 17 | 0.090 |
Why?
|
Cohort Studies | 6 | 2022 | 41317 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2020 | 2927 | 0.090 |
Why?
|
Cell Division | 5 | 2011 | 4462 | 0.090 |
Why?
|
Cytotoxicity, Immunologic | 3 | 2021 | 1351 | 0.090 |
Why?
|
Receptors, Notch | 3 | 2022 | 742 | 0.090 |
Why?
|
MicroRNAs | 2 | 2018 | 3784 | 0.090 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 1137 | 0.090 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2021 | 498 | 0.090 |
Why?
|
Dipyridamole | 1 | 2010 | 143 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6545 | 0.090 |
Why?
|
Etoposide | 1 | 2011 | 630 | 0.090 |
Why?
|
RNA Interference | 2 | 2016 | 2846 | 0.090 |
Why?
|
Tumor Escape | 2 | 2024 | 371 | 0.090 |
Why?
|
Stress, Physiological | 1 | 2017 | 1395 | 0.080 |
Why?
|
Furans | 1 | 2010 | 199 | 0.080 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2014 | 730 | 0.080 |
Why?
|
Wnt Proteins | 1 | 2013 | 718 | 0.080 |
Why?
|
Radiotherapy Dosage | 1 | 2016 | 2897 | 0.080 |
Why?
|
Pyrazines | 1 | 2015 | 1200 | 0.080 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2012 | 496 | 0.080 |
Why?
|
Middle Aged | 23 | 2024 | 220175 | 0.080 |
Why?
|
Telomere | 1 | 2015 | 934 | 0.080 |
Why?
|
alpha-Fetoproteins | 3 | 2002 | 222 | 0.080 |
Why?
|
Trigeminal Neuralgia | 1 | 2009 | 106 | 0.080 |
Why?
|
Oncogenes | 1 | 2014 | 1221 | 0.080 |
Why?
|
Combined Modality Therapy | 6 | 2020 | 8551 | 0.080 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2014 | 2500 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 4 | 2020 | 2804 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4355 | 0.070 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1447 | 0.070 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2014 | 938 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2024 | 4875 | 0.070 |
Why?
|
Cell Lineage | 3 | 2024 | 2525 | 0.070 |
Why?
|
Drug Delivery Systems | 2 | 2018 | 2218 | 0.070 |
Why?
|
Retrospective Studies | 7 | 2024 | 80301 | 0.070 |
Why?
|
Histones | 3 | 2023 | 2583 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2022 | 5644 | 0.070 |
Why?
|
Cerebellopontine Angle | 1 | 2006 | 53 | 0.070 |
Why?
|
Capsid Proteins | 1 | 2009 | 467 | 0.070 |
Why?
|
Aged | 18 | 2024 | 168995 | 0.070 |
Why?
|
Histone Demethylases | 2 | 2020 | 323 | 0.070 |
Why?
|
Polymerase Chain Reaction | 6 | 2011 | 6067 | 0.060 |
Why?
|
Male | 29 | 2024 | 359413 | 0.060 |
Why?
|
Epidermal Cyst | 1 | 2006 | 64 | 0.060 |
Why?
|
Lac Operon | 4 | 2002 | 237 | 0.060 |
Why?
|
Young Adult | 9 | 2024 | 58673 | 0.060 |
Why?
|
Transplantation, Heterologous | 2 | 2011 | 2378 | 0.060 |
Why?
|
Rats, Inbred F344 | 2 | 2004 | 825 | 0.060 |
Why?
|
Adult | 20 | 2024 | 219847 | 0.060 |
Why?
|
Carcinoembryonic Antigen | 2 | 1996 | 336 | 0.060 |
Why?
|
Child | 7 | 2023 | 79758 | 0.060 |
Why?
|
Phenotype | 2 | 2014 | 16543 | 0.060 |
Why?
|
Receptors, Progesterone | 2 | 2022 | 1122 | 0.060 |
Why?
|
Stem Cells | 2 | 2023 | 3525 | 0.060 |
Why?
|
Dependovirus | 1 | 2009 | 708 | 0.060 |
Why?
|
Bystander Effect | 2 | 2018 | 90 | 0.060 |
Why?
|
RNA Polymerase III | 1 | 2024 | 59 | 0.060 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2021 | 1090 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6830 | 0.060 |
Why?
|
Mice, Inbred NOD | 2 | 2019 | 1837 | 0.050 |
Why?
|
Callithrix | 1 | 2003 | 93 | 0.050 |
Why?
|
Thymidine Kinase | 3 | 2004 | 286 | 0.050 |
Why?
|
Ganciclovir | 3 | 2004 | 252 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8058 | 0.050 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2003 | 65 | 0.050 |
Why?
|
Carbon Radioisotopes | 1 | 2024 | 557 | 0.050 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2002 | 2297 | 0.050 |
Why?
|
Herpesvirus 2, Human | 1 | 2024 | 190 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2001 | 5201 | 0.050 |
Why?
|
Nucleotidyltransferases | 1 | 2024 | 244 | 0.050 |
Why?
|
Peptides | 2 | 2013 | 4358 | 0.050 |
Why?
|
Rats | 6 | 2004 | 23695 | 0.050 |
Why?
|
Oncostatin M Receptor beta Subunit | 1 | 2021 | 4 | 0.050 |
Why?
|
Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2021 | 15 | 0.050 |
Why?
|
Radiotherapy | 2 | 2010 | 1505 | 0.050 |
Why?
|
Astrocytes | 2 | 2024 | 1335 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2019 | 21065 | 0.050 |
Why?
|
Methylation | 2 | 2016 | 1080 | 0.050 |
Why?
|
Cytokine Receptor gp130 | 1 | 2021 | 66 | 0.050 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2024 | 616 | 0.050 |
Why?
|
RNA | 2 | 2024 | 2721 | 0.050 |
Why?
|
Oncostatin M | 1 | 2021 | 42 | 0.050 |
Why?
|
Ligands | 2 | 2018 | 3277 | 0.050 |
Why?
|
Cholinergic Agonists | 1 | 2001 | 75 | 0.050 |
Why?
|
Gene Expression | 3 | 2014 | 7592 | 0.050 |
Why?
|
Gene Expression Profiling | 4 | 2021 | 9388 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4573 | 0.050 |
Why?
|
Base Sequence | 4 | 2016 | 12447 | 0.050 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2003 | 414 | 0.050 |
Why?
|
Receptor, Notch1 | 1 | 2024 | 495 | 0.050 |
Why?
|
Cerebellar Neoplasms | 1 | 2006 | 585 | 0.050 |
Why?
|
Carbachol | 1 | 2001 | 223 | 0.050 |
Why?
|
Disease Progression | 6 | 2020 | 13505 | 0.050 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2024 | 503 | 0.050 |
Why?
|
Models, Animal | 2 | 2006 | 2117 | 0.050 |
Why?
|
Survival Rate | 5 | 2020 | 12806 | 0.050 |
Why?
|
Interferon-gamma | 2 | 2022 | 3160 | 0.050 |
Why?
|
Positron-Emission Tomography | 3 | 2024 | 6457 | 0.050 |
Why?
|
DNA Transposable Elements | 1 | 2024 | 752 | 0.040 |
Why?
|
Complement Activation | 1 | 2002 | 446 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2001 | 256 | 0.040 |
Why?
|
T-Lymphocyte Subsets | 2 | 2021 | 1811 | 0.040 |
Why?
|
Enzyme Activation | 3 | 2015 | 3604 | 0.040 |
Why?
|
Killer Cells, Natural | 2 | 2021 | 2204 | 0.040 |
Why?
|
Adolescent | 9 | 2023 | 87747 | 0.040 |
Why?
|
Thiadiazoles | 1 | 2019 | 64 | 0.040 |
Why?
|
Sirtuin 1 | 1 | 2021 | 247 | 0.040 |
Why?
|
HeLa Cells | 4 | 2015 | 3105 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2022 | 642 | 0.040 |
Why?
|
Caspases | 2 | 2018 | 878 | 0.040 |
Why?
|
Viral Matrix Proteins | 1 | 2020 | 197 | 0.040 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2009 | 1401 | 0.040 |
Why?
|
Benzodiazepinones | 1 | 2018 | 50 | 0.040 |
Why?
|
Xenopus Proteins | 1 | 2002 | 434 | 0.040 |
Why?
|
Sex Chromatin | 1 | 2018 | 19 | 0.040 |
Why?
|
Cell Nucleolus | 1 | 2019 | 156 | 0.040 |
Why?
|
Genetic Variation | 1 | 2014 | 6540 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2021 | 18968 | 0.040 |
Why?
|
Postoperative Period | 1 | 2023 | 1821 | 0.040 |
Why?
|
Brain | 8 | 2023 | 26912 | 0.040 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2002 | 461 | 0.040 |
Why?
|
Cell Survival | 3 | 2017 | 5796 | 0.040 |
Why?
|
Gene Knockdown Techniques | 2 | 2015 | 1617 | 0.040 |
Why?
|
Receptors, Death Domain | 1 | 2018 | 31 | 0.040 |
Why?
|
Empyema, Subdural | 1 | 1998 | 12 | 0.040 |
Why?
|
Promoter Regions, Genetic | 3 | 2020 | 5784 | 0.040 |
Why?
|
Hemangiopericytoma | 1 | 1998 | 71 | 0.040 |
Why?
|
Liver Neoplasms | 3 | 2002 | 4317 | 0.040 |
Why?
|
Genes, Transgenic, Suicide | 1 | 2018 | 35 | 0.040 |
Why?
|
RNA, Ribosomal | 1 | 2019 | 226 | 0.040 |
Why?
|
Immunization | 1 | 2023 | 1228 | 0.040 |
Why?
|
Progesterone | 1 | 2022 | 742 | 0.040 |
Why?
|
Immunoconjugates | 2 | 2018 | 949 | 0.040 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2018 | 112 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2020 | 58947 | 0.040 |
Why?
|
Cardiotonic Agents | 1 | 2001 | 546 | 0.040 |
Why?
|
Protein Stability | 1 | 2019 | 566 | 0.040 |
Why?
|
Sequence Analysis, RNA | 2 | 2017 | 2003 | 0.040 |
Why?
|
Species Specificity | 1 | 2002 | 2413 | 0.040 |
Why?
|
Lectins, C-Type | 1 | 2021 | 591 | 0.040 |
Why?
|
DNA Methylation | 2 | 2024 | 4374 | 0.040 |
Why?
|
Brain Abscess | 1 | 1998 | 120 | 0.040 |
Why?
|
Genes, gag | 1 | 1997 | 56 | 0.040 |
Why?
|
Tumor Stem Cell Assay | 1 | 2017 | 115 | 0.040 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2022 | 1790 | 0.040 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2001 | 865 | 0.040 |
Why?
|
Ligaments | 1 | 1997 | 127 | 0.040 |
Why?
|
Uterine Prolapse | 1 | 1997 | 70 | 0.040 |
Why?
|
Cadherins | 1 | 2021 | 898 | 0.040 |
Why?
|
Immunomodulation | 1 | 2021 | 547 | 0.040 |
Why?
|
Pulmonary Fibrosis | 1 | 2021 | 507 | 0.040 |
Why?
|
STAT3 Transcription Factor | 1 | 2021 | 877 | 0.030 |
Why?
|
Epigenesis, Genetic | 2 | 2024 | 3758 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2018 | 697 | 0.030 |
Why?
|
Flow Cytometry | 4 | 2013 | 5873 | 0.030 |
Why?
|
Cell Line | 3 | 2017 | 15626 | 0.030 |
Why?
|
Prodrugs | 1 | 2018 | 259 | 0.030 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2020 | 581 | 0.030 |
Why?
|
Defective Viruses | 1 | 1996 | 89 | 0.030 |
Why?
|
Pentosyltransferases | 1 | 2015 | 62 | 0.030 |
Why?
|
Stomach Neoplasms | 2 | 1996 | 1423 | 0.030 |
Why?
|
Genomics | 2 | 2023 | 5790 | 0.030 |
Why?
|
Autonomic Nervous System | 1 | 2001 | 697 | 0.030 |
Why?
|
Picibanil | 1 | 1995 | 10 | 0.030 |
Why?
|
Drug Repositioning | 1 | 2018 | 231 | 0.030 |
Why?
|
Elastin | 1 | 1997 | 301 | 0.030 |
Why?
|
Isoquinolines | 1 | 2017 | 353 | 0.030 |
Why?
|
Sulfasalazine | 1 | 2016 | 84 | 0.030 |
Why?
|
Central Nervous System | 1 | 2003 | 1334 | 0.030 |
Why?
|
Chromatin | 2 | 2021 | 2939 | 0.030 |
Why?
|
Immunoenzyme Techniques | 2 | 1996 | 1705 | 0.030 |
Why?
|
Cystine | 1 | 2016 | 94 | 0.030 |
Why?
|
Infant | 4 | 2023 | 36030 | 0.030 |
Why?
|
NF-kappa B | 2 | 2020 | 2486 | 0.030 |
Why?
|
DNA Primers | 2 | 1997 | 2819 | 0.030 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2016 | 174 | 0.030 |
Why?
|
Hepatocyte Growth Factor | 1 | 1997 | 267 | 0.030 |
Why?
|
Protein Binding | 2 | 2019 | 9336 | 0.030 |
Why?
|
Green Fluorescent Proteins | 2 | 2012 | 2056 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2024 | 4109 | 0.030 |
Why?
|
Telomeric Repeat Binding Protein 2 | 1 | 2015 | 20 | 0.030 |
Why?
|
Phosphorylation | 2 | 2019 | 8314 | 0.030 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2017 | 428 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1997 | 778 | 0.030 |
Why?
|
Immunoblotting | 2 | 2011 | 1649 | 0.030 |
Why?
|
Replication Protein A | 1 | 2015 | 52 | 0.030 |
Why?
|
Growth Substances | 1 | 1997 | 768 | 0.030 |
Why?
|
Antigens, Surface | 1 | 2019 | 1616 | 0.030 |
Why?
|
Child, Preschool | 4 | 2023 | 42034 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 3804 | 0.030 |
Why?
|
Recombinant Proteins | 4 | 1997 | 6543 | 0.030 |
Why?
|
Cytosine Deaminase | 3 | 2002 | 65 | 0.030 |
Why?
|
3T3 Cells | 1 | 1996 | 1085 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2015 | 329 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 1062 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2017 | 939 | 0.030 |
Why?
|
Co-Repressor Proteins | 1 | 2014 | 191 | 0.030 |
Why?
|
Genetic Markers | 2 | 1997 | 2608 | 0.030 |
Why?
|
Biomimetic Materials | 1 | 2014 | 173 | 0.030 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2014 | 183 | 0.030 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2013 | 84 | 0.030 |
Why?
|
Immunosuppressive Agents | 2 | 2003 | 4168 | 0.030 |
Why?
|
Cell Death | 1 | 2018 | 1670 | 0.030 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 1995 | 412 | 0.030 |
Why?
|
RNA Splicing | 1 | 2017 | 914 | 0.030 |
Why?
|
Transplantation, Isogeneic | 1 | 2012 | 248 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2002 | 2414 | 0.030 |
Why?
|
Cytopathogenic Effect, Viral | 1 | 2012 | 151 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2015 | 600 | 0.030 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 1996 | 640 | 0.030 |
Why?
|
Lysine | 1 | 2016 | 1002 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 1996 | 1765 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2001 | 2441 | 0.020 |
Why?
|
Genome, Viral | 1 | 1995 | 658 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 1 | 2002 | 2255 | 0.020 |
Why?
|
Gene Order | 1 | 2012 | 169 | 0.020 |
Why?
|
Receptors, Virus | 1 | 1995 | 639 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 943 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2012 | 384 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2825 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2024 | 3618 | 0.020 |
Why?
|
Mice, Inbred A | 1 | 2011 | 246 | 0.020 |
Why?
|
Th1 Cells | 1 | 1996 | 1033 | 0.020 |
Why?
|
RNA, Untranslated | 1 | 2015 | 459 | 0.020 |
Why?
|
Carotid Arteries | 1 | 1995 | 951 | 0.020 |
Why?
|
DNA Modification Methylases | 1 | 2011 | 208 | 0.020 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2012 | 180 | 0.020 |
Why?
|
Tissue Distribution | 2 | 2007 | 2262 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2012 | 670 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 1663 | 0.020 |
Why?
|
Hemodynamics | 1 | 2001 | 4169 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2016 | 1166 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7236 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2006 | 4024 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2004 | 4357 | 0.020 |
Why?
|
Flucytosine | 2 | 2002 | 32 | 0.020 |
Why?
|
Ribonucleotide Reductases | 1 | 2010 | 76 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1356 | 0.020 |
Why?
|
DNA Shuffling | 1 | 2009 | 5 | 0.020 |
Why?
|
Molecular Sequence Data | 3 | 1997 | 17628 | 0.020 |
Why?
|
DNA Repair Enzymes | 1 | 2011 | 345 | 0.020 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2010 | 132 | 0.020 |
Why?
|
Protein Kinases | 1 | 2016 | 1612 | 0.020 |
Why?
|
DNA Helicases | 1 | 2015 | 854 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2018 | 1892 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1995 | 1484 | 0.020 |
Why?
|
Disease Management | 1 | 2020 | 2508 | 0.020 |
Why?
|
Osteosarcoma | 1 | 2015 | 898 | 0.020 |
Why?
|
Mice, Inbred BALB C | 3 | 2006 | 6226 | 0.020 |
Why?
|
Transcription, Genetic | 3 | 2016 | 7593 | 0.020 |
Why?
|
Gastrointestinal Neoplasms | 1 | 1996 | 951 | 0.020 |
Why?
|
Radiosurgery | 2 | 2010 | 1343 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9531 | 0.020 |
Why?
|
Treatment Outcome | 5 | 2018 | 64947 | 0.020 |
Why?
|
Immunotherapy, Adoptive | 2 | 1996 | 1442 | 0.020 |
Why?
|
Microglia | 1 | 2017 | 1348 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2016 | 2138 | 0.020 |
Why?
|
Antioxidants | 1 | 2016 | 1668 | 0.020 |
Why?
|
Camptothecin | 1 | 2011 | 590 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2010 | 796 | 0.020 |
Why?
|
Electrocardiography | 1 | 2001 | 6413 | 0.020 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2011 | 625 | 0.020 |
Why?
|
Epigenomics | 1 | 2013 | 936 | 0.020 |
Why?
|
RNA, Viral | 1 | 1995 | 2837 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11341 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2013 | 1548 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2010 | 1340 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 3076 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10530 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2012 | 1135 | 0.020 |
Why?
|
Gene Library | 1 | 2009 | 1060 | 0.020 |
Why?
|
Tumor Burden | 1 | 2012 | 1897 | 0.020 |
Why?
|
Cell Membrane | 1 | 2016 | 3683 | 0.020 |
Why?
|
Metabolomics | 1 | 2015 | 1626 | 0.020 |
Why?
|
Chemokine CCL21 | 1 | 2006 | 51 | 0.020 |
Why?
|
Genes, p53 | 2 | 1999 | 714 | 0.020 |
Why?
|
Adenine | 1 | 2012 | 976 | 0.020 |
Why?
|
Graft Rejection | 2 | 1996 | 4423 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1655 | 0.020 |
Why?
|
Time Factors | 4 | 2015 | 40133 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2012 | 1483 | 0.020 |
Why?
|
Caspase 3 | 1 | 2007 | 730 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2651 | 0.020 |
Why?
|
Chemokines, CC | 1 | 2006 | 283 | 0.020 |
Why?
|
Blood Vessels | 1 | 2010 | 1112 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2015 | 2869 | 0.010 |
Why?
|
CD40 Ligand | 1 | 2006 | 522 | 0.010 |
Why?
|
Mice, Inbred DBA | 2 | 1995 | 622 | 0.010 |
Why?
|
Lung | 1 | 2021 | 9989 | 0.010 |
Why?
|
Diuretics, Osmotic | 1 | 2002 | 33 | 0.010 |
Why?
|
Antibodies, Monoclonal | 2 | 1996 | 9196 | 0.010 |
Why?
|
Genome, Human | 1 | 2015 | 4416 | 0.010 |
Why?
|
Heparin | 1 | 2009 | 1655 | 0.010 |
Why?
|
Infusions, Intra-Arterial | 1 | 2002 | 221 | 0.010 |
Why?
|
Mannitol | 1 | 2002 | 180 | 0.010 |
Why?
|
Genes, erbB-1 | 1 | 2002 | 160 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2014 | 4409 | 0.010 |
Why?
|
Superoxide Dismutase | 1 | 2004 | 594 | 0.010 |
Why?
|
Neuroblastoma | 1 | 2009 | 1252 | 0.010 |
Why?
|
Gadolinium | 1 | 2006 | 959 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2018 | 36247 | 0.010 |
Why?
|
Plasmids | 1 | 2006 | 2277 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8621 | 0.010 |
Why?
|
Interleukin-8 | 1 | 2004 | 698 | 0.010 |
Why?
|
Elapid Venoms | 1 | 2000 | 41 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26168 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2004 | 1250 | 0.010 |
Why?
|
Patch-Clamp Techniques | 1 | 2002 | 932 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1997 | 11902 | 0.010 |
Why?
|
Electrophysiology | 1 | 2002 | 1265 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 2002 | 1760 | 0.010 |
Why?
|
Biopsy | 1 | 2010 | 6775 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39254 | 0.010 |
Why?
|
Virus Activation | 1 | 2000 | 319 | 0.010 |
Why?
|
Cisplatin | 1 | 2004 | 1642 | 0.010 |
Why?
|
Potassium | 1 | 2002 | 1318 | 0.010 |
Why?
|
Thymidine | 1 | 1997 | 299 | 0.010 |
Why?
|
PTEN Phosphohydrolase | 1 | 2003 | 1115 | 0.010 |
Why?
|
Organ Specificity | 1 | 2002 | 1955 | 0.010 |
Why?
|
Vascular Neoplasms | 1 | 1998 | 167 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2001 | 1900 | 0.010 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 1996 | 221 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2003 | 1791 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 1996 | 5797 | 0.010 |
Why?
|
Immunoglobulin Isotypes | 1 | 1996 | 158 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2005 | 15273 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2011 | 14396 | 0.010 |
Why?
|
United States | 1 | 2024 | 72363 | 0.010 |
Why?
|
Hypersensitivity, Delayed | 1 | 1996 | 490 | 0.010 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 1995 | 220 | 0.010 |
Why?
|
Image Enhancement | 1 | 2006 | 2877 | 0.010 |
Why?
|
Genes, Viral | 1 | 1996 | 650 | 0.010 |
Why?
|
Heterozygote | 1 | 2002 | 2797 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 1998 | 20484 | 0.010 |
Why?
|
Antibody Formation | 1 | 1999 | 1400 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 1999 | 1529 | 0.010 |
Why?
|
Action Potentials | 1 | 2002 | 1814 | 0.010 |
Why?
|
Interleukin-7 | 1 | 1994 | 142 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2004 | 3207 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 1997 | 567 | 0.010 |
Why?
|
Gene Expression Regulation, Viral | 1 | 1995 | 438 | 0.010 |
Why?
|
Myocytes, Cardiac | 1 | 2002 | 1656 | 0.010 |
Why?
|
Tachycardia, Ventricular | 1 | 2002 | 1302 | 0.010 |
Why?
|
Exons | 1 | 1999 | 2391 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1996 | 1128 | 0.010 |
Why?
|
Genes, Reporter | 1 | 1996 | 1531 | 0.010 |
Why?
|
Spinal Neoplasms | 1 | 1998 | 716 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 1997 | 1745 | 0.010 |
Why?
|
Fluorouracil | 1 | 1996 | 1630 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2004 | 3061 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 74269 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2004 | 5120 | 0.010 |
Why?
|
Brain Edema | 1 | 1995 | 603 | 0.010 |
Why?
|
Catheterization | 1 | 1995 | 1432 | 0.010 |
Why?
|
Drug Resistance | 1 | 1996 | 1617 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1997 | 2104 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 1996 | 1354 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 1997 | 1614 | 0.010 |
Why?
|
Rabbits | 1 | 1995 | 4773 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 1999 | 4286 | 0.000 |
Why?
|
Epitopes | 1 | 1994 | 2506 | 0.000 |
Why?
|
Antibodies, Viral | 1 | 1999 | 3145 | 0.000 |
Why?
|
Kidney | 1 | 2003 | 7072 | 0.000 |
Why?
|
Transplantation, Homologous | 1 | 1996 | 4814 | 0.000 |
Why?
|
Liver | 1 | 2003 | 7512 | 0.000 |
Why?
|
Receptors, Estrogen | 1 | 1995 | 2202 | 0.000 |
Why?
|
Neurosurgical Procedures | 1 | 1998 | 2056 | 0.000 |
Why?
|
Fibroblasts | 1 | 1997 | 4091 | 0.000 |
Why?
|
Uterine Neoplasms | 1 | 1996 | 1434 | 0.000 |
Why?
|
Vaccines | 1 | 1995 | 833 | 0.000 |
Why?
|
Graft Survival | 1 | 1996 | 3793 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1996 | 13456 | 0.000 |
Why?
|
Decision Making | 1 | 1998 | 3924 | 0.000 |
Why?
|
Vaccination | 1 | 1995 | 3360 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1995 | 12968 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 1998 | 7400 | 0.000 |
Why?
|
Pancreatic Neoplasms | 1 | 1996 | 5333 | 0.000 |
Why?
|
Colorectal Neoplasms | 1 | 1996 | 6855 | 0.000 |
Why?
|